HR+, HER2-, Advanced Breast Cancer trials recruiting in Ohio

All HR+, HER2-, Advanced Breast Cancer trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
  NCT06827613 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
  NCT06998407 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland, Columbus
• Study of AVZO-021 in Patients With Advanced Solid Tumors
  NCT05867251 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland